SEARCH

SEARCH BY CITATION

References

  • 1
    Olefsky JM & Molina JM. Insulin resistance in man. In: RiffinH, PorteDJ, eds. Diabetes Mellitus. 4th edn. New York: Elsevier Science Publishing Co., Inc.; 1990. p. 121 53.
  • 2
    Moller DE. Insulin Resistance. UK: John Wiley & Sons Ltd.; 1993.
  • 3
    Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in Glut4. Nature 1995; 377151 55.
  • 4
    Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM. Decreased kinase activity of insulin receptors from adipocytes of non insulin-dependent diabetic subjects. J Clin Invest 1987; 79(l): 240 50.
  • 5
    Saad Mja, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 1992; 901839 49.
  • 6
    Reynet C & Kahn CR. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993; 262: 1441 4.
  • 7
    Maddux BA, Sbraccia P, Kumakura S, Sasson S, Youngren J, Fisher A. et al. Membrane glycoprotein PC-1 and insulin resistance in non-insulin dependent diabetes mellitus. Nature 1995; 373: 448 51.
  • 8
    Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185 8.
  • 9
    Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46(1): 3 10(review).
  • 10
    Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87 91.
  • 11
    Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94(4): 1543 9.
  • 12
    Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 1996; 274(5291): 1377 9.
  • 13
    Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk Bjjr, Hotamisligil GS et al. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinol 1994; 134: 264 70.
  • 14
    Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 1995; 44: 1266 73.
  • 15
    Cheung AT, Ree D, Kolls Jkjf, Coy DH, Bryer-Ash M. An in vivo model for elucidation of the mechanism of TNF-α induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-α. Endocrinol 1998; 139: 4928 35.
  • 16
    Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409 15.
  • 17
    Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95(5): 2111 9.
  • 18
    Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF by human muscle: relationship to insulin resistance. J Clin Invest 1996; 97: 1111 16.
  • 19
    Dandona P, Weinstock R, Thusu K, Abdelrahman EA, Ijada A, Wadden T. Tumor necrosis factor-alpha in sera of obese patients – Fall with weight loss. J Clin Endocrinol Metab 1998; 83(8): 2907 10.
  • 20
    Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with Non-Insulin-Dependent Diabetes Mellitus. Arterio Thromb Vasc Biol 1998; 18(8): 1199 1202.
  • 21
    Winkler G, Salamon F, Salamon Dgs, Simon K, Cseh K. Elevated serum tumor necrosis factor-alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 1998; 41: 860 61.
  • 22
    Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J. Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes -Implication of the P80 tumor necrosis factor receptor. Diabetes 1998; 47(4): 515 22.
  • 23
    Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNFα antibody (C1), P571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996 ; 45: 881 5.
  • 24
    Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. TNFα inhibits signaling from insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854 8.
  • 25
    Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 1993; 268: 26055 8.
  • 26
    Hotamisligil GH, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNFα and obesity-induced insulin resistance. Science 1996; 271: 665 8.
  • 27
    Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Mühlhöfer A et al. Tumor necrosis factor-α and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 1996; 97: 1471 7.
  • 28
    Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995; 270(40): 23780 84.
  • 29
    Kellerer M, Mushack J, Mischak H, Haring HU. Protein kinase C (PKC) epsilon enhances the inhibitory effect of TNF alpha on insulin signaling in HEK293 cells. FEBS Lett 1997; 418(1–2): 119 22.
  • 30
    Kellerer M, Mushack J, Seffer E, Mischak H, Ullrich A, Haring HU. Protein Kinase C isoforms alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (Hek 293 Cells). Diabetologia 1998; 41(7): 833 8.
  • 31
    Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997; 272: 29911 18.
  • 32
    Peraldi P, Hotamisligil GS, Buurman WA, White W, Spiegelman BM. Tumor necrosis factor (TNF)α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996; 271: 13018 22.
  • 33
    Valverde AM, Teruel T, Navarro P, Benito M, Lorenzo M. Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes. Endocrinol 1998; 139(3): 1229 38.
  • 34
    Uysal KT, Wiesbrock SM, Marino MM, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389(6651): 610 14.
  • 35
    Uysal KT, Wiesbrock SM, Hotamisligil GS. Functional anyalysis of TNF receptors in TN17-alpha-mediated insulin resistance in genetic obesity. Endocrinol 1998; 139: 4832 38.
  • 36
    Ventre J, Doebber T, Wu M, Macnaul K, Stevens K, Pasparakis M et al. Targeted disruption of the tumor necrosis factor-alpha gene – Metabolic consequences in obese and nonobese mice. Diabetes 1997; 46(9): 1526 31.
  • 37
    Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100(11): 2777 82.